Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt
Objectives: To study the epidemiological and demographic data of retinopathy of prematurity (ROP) as well as the effectiveness of intravitreal injection of bevacizumab (IVB) as monotherapy for type I ROP in a local neonatal intensive care unit in Egypt. Methods: An observational study, where the med...
Saved in:
| Main Authors: | Ehab Mohamed Hantash, Abdulrahman Abdullah Al Zahrani, Yasser Ragab Serag |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-04-01
|
| Series: | Dr. Sulaiman Al Habib Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/DSHMJ.DSHMJ_33_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Intravitreal Bevacizumab in Retinopathy of Prematurity (ROP) in a Tertiary Eye Care Centre in Eastern India: A Retrospective Analysis
by: Santosh Kumar Mahapatra, et al.
Published: (2022-07-01) -
Incidence and Outcome of Retinopathy of Prematurity (ROP): An Observational Study from a Private Hospital in Saudi Arabia
by: Abdulrahman A. Al Zahrani, et al.
Published: (2025-01-01) -
Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity
by: Anthony A. Jones, et al.
Published: (2024-12-01) -
Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity
by: Joyce Wang, BS, et al.
Published: (2025-11-01) -
Retinopathy of Prematurity - a literature review
by: Małgorzata Zach, et al.
Published: (2025-07-01)